Get the Flash Player to see this player.
Content Providers
Company News
Globes, 18/3/2015 - Leumi to report NIS 290m profit on Mobileye share sale
Bank Leumi also sold Mobileye shares in 2014, making profits of NIS 143 million and NIS 16 million. More Info

Globes, 18/3/2015 - Teva teams with Ignyta on oncology treatment
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company. More Info

Seeking Alpha, 17/3/2015 - Teva Pharmaceutical: Bold Markets, Bold Moves
More Info

Globes, 16/3/2015 - Cellcom reports lower revenue, higher profit
Cellcom CEO Nit Sztern: We'll have over 20,000 Cellcom tv subscribers by the end of March. More Info

Speculation grows that Teva close to giant M&A deal, 16/3/2015 - Speculation grows that Teva close to giant M&A deal
More Info

Globes, 15/3/2015 - Bank Hapoalim confirms 600-700 layoffs
The Israel Securities Authority demanded disclosure of details of the bank's streamlining plan. More Info

Globes, 15/3/2015 - Teva's share price near all-time high
Teva's share price is now at $60 for the first time since 2010. More Info

Seeking Alpha, 11/3/2015 - Partner Communications' (PTNR) CEO Haim Romano on Q4 2014 Results - Earnings Call Transcript
More Info

Seeking Alpha, 11/3/2015 - Partner Communications Company (PTNR) Q4 2014 Results - Earnings Call Webcast
More Info

Israel's Discount Bank reports sharp drop in 4Q profit, 10/3/2015 - Israel's Discount Bank reports sharp drop in 4Q profit
More Info

Globes, 26/1/2015 - Teva gets first "Sell" recommendation
Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. More Info

Globes, 25/1/2015 - Report of Pfizer acquisition approach boosts Teva
According to Bloomberg, Pfizer made the approach late last year, but was rebuffed. More Info

Seeking Alpha, 22/1/2015 - Teva Pharmaceutical: An Ambitious Bet
More Info

Globes, 22/1/2015 - Hadasit Bio jumps on EMA orphan drug status
Enlivex Therapeutics is developing Apocell for treating graft-versus-host disease in bone marrow transplants. More Info

Globes, 21/1/2015 - US Supreme Court upholds Copaxone patent
The ruling means Teva's flagship multiple sclerosis treatment's patent remains valid until September 2015. More Info

Globes, 21/1/2015 - UBS sees upside in Cellcom, Partner share prices
Analyst Roni Biran: We see plenty of upside should current dynamics and market structure prove unsustainable. More Info

Teva’s choice: rapid earnings growth or investment in R&D, 21/1/2015 - Teva’s choice: rapid earnings growth or investment in R&D
More Info

U.S. Supreme Court sides with Teva in drug dispute, 20/1/2015 - U.S. Supreme Court sides with Teva in drug dispute
More Info

Globes, 19/1/2015 - Asian army orders Elbit missile protection systems
Elbit Systems mini MUSIC IR MWS based DIRCM will protect the army's Blackhawk helicopters from heat seeking missiles. More Info

Globes, 18/1/2015 - BoI spikes Wertheim succession at Mizrahi Tefahot
The Bank of Israel is not granting a bank control permit to Mozi Wertheim's children David and Drorit. More Info

Seeking Alpha, 7/1/2015 - Teva: New Generic Launches Will Benefit Earnings
More Info

Cellcom to launch television service next week, 24/12/2014 - Cellcom to launch television service next week
More Info

Globes, 23/12/2014 - FDA approves Teva's GRANIX for self-administration
From early 2015 patients will themselves be able to administer the treatment for neutropenia, associated with leukemia. More Info

Globes, 23/12/2014 - Elbit Systems wins $106m Brazilian Navy upgrade
Elbit Systems will upgrade four Grumman C-1A aircraft at its M7 Aerospace unit in San Antonio, Texas. More Info

Globes, 21/12/2014 - ScotiaBank to buy Discount Bank Latin America
ScotiaBank has signed an agreement to buy Israel Discount Bank's Uruguay unit for $65 million. More Info

Globes, 21/12/2014 - FDA approves Teva allergy spray for children
The QNASL nasal spray, approved for adults in 2012, treats nasal symptoms for allergic rhinitis, including hay fever, in children. More Info

Globes, 18/12/2014 - Teva and Russian partner at loggerheads
Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. More Info

Globes, 17/12/2014 - US court delays Teva launch of generic Celebrex
Teva has lost its 180 days exclusivity for the generic version of Pfizer's arthritis and chronic pain treatment. More Info

Globes, 17/12/2014 - Discount Bank sells 2% First Int'l Bank stake
After Discount Bank sells the shares for NIS 100 million, it will have a 16.5% holding in First International Bank. More Info

Globes, 16/12/2014 - "Copaxone risk dramatically down"
Bank of Jerusalem Brokerage has upgraded its recommendation on Teva. More Info

Find Company by Name:
Find Company by Industry:
Find Company by Stock Exchange:
Find Company by Index:
language: German French Spanish
Sign-up for free digital directories
Sign-up to receive free newsletter

© Copyright 2016 | Terms & Conditions | Site Map | Contact Us | Tel Aviv Stock Exchange | Find a lawyer in Israel | Find a CPA in Israel | News releases from Israel Created by: Logics - פיתוח תוכנה ואינטרנט

Reprinted from the Equities Israel web site -